Adtalem Global Education (NYSE:CVSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Barrington Research in a research note issued on Friday,Benzinga reports. They currently have a $170.00 price objective on the stock. Barrington Research’s price objective would suggest a potential upside of 44.00% from the company’s current price.
CVSA has been the subject of a number of other reports. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Truist Financial assumed coverage on shares of Adtalem Global Education in a research note on Tuesday, March 24th. They issued a “buy” rating and a $130.00 price target for the company. Finally, Weiss Ratings assumed coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $150.00.
View Our Latest Report on CVSA
Adtalem Global Education Price Performance
Adtalem Global Education (NYSE:CVSA – Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share for the quarter. The company had revenue of $503.39 million during the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%.
Insider Activity
In other news, Director Michael W. Malafronte acquired 8,890 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The stock was acquired at an average cost of $100.94 per share, with a total value of $897,356.60. Following the acquisition, the director owned 25,395 shares in the company, valued at approximately $2,563,371.30. This represents a 53.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Over the last ninety days, insiders have acquired 37,236 shares of company stock worth $3,752,866. 2.50% of the stock is currently owned by corporate insiders.
Adtalem Global Education Company Profile
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Recommended Stories
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
